Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry-Reference-Cited by-同舟云学术

Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry

Published:2017-04-07 Issue:6 Volume:40 Page:347-355
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Pitts Reynaria¹,Daugherty Stacie L.¹²,Tang Fengming³,Jones Philip³,Ho P. Michael¹⁴,Tsai Thomas T.²⁵,Spertus John³,Maddox Thomas M.¹⁴^ORCID

Affiliation:

1. University of Colorado School of Medicine; Aurora Colorado

2. Colorado Cardiovascular Outcomes Research Consortium; Denver Colorado

3. Saint Luke's/Mid America Heart Institute and the University of Missouri-Kansas City; Kansas City Kansas

4. VA Eastern Colorado Health Care System; Denver Colorado

5. Institute for Health Research; Kaiser Permanente Denver Colorado

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference30 articles.

1. Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients;De Ferrari;Eur Heart J Acute Cardiovasc Care.,2013

2. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative;Patel;Am Heart J.,2006

3. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial;Planer;Circ Cardiovasc Interv.,2014

4. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators;Roe;Circulation,2000

5. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med.,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial infarction with non-obstructive coronary arteries (MINOCA);Frontiers in Cardiovascular Medicine;2022-11-15

2. Do Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries Have Similar Prognosis Compared to Ones with MI-CAD?;Angiology;2022-08-22

3. Role of apolipoprotein O in autophagy via the p38 mitogen-activated protein kinase signaling pathway in myocardial infarction;Clinics;2022-01

4. Gender Differences in Non-Obstructive Coronary Artery Disease;Current Pharmaceutical Design;2021-09-23

5. OCT Findings in MINOCA;Journal of Clinical Medicine;2021-06-23